Unknown

Dataset Information

0

Novel botanical drug DA-9803 prevents deficits in Alzheimer's mouse models.


ABSTRACT:

Background

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by deposition of amyloid plaques and disruption of neural circuitry, leading to cognitive decline. Animal models of AD deposit senile plaques and exhibit structural and functional deficits in neurons and neural networks. An effective treatment would prevent or restore these deficits, including calcium dyshomeostasis observed with in-vivo imaging.

Methods

We examined the effects of DA-9803, a multimodal botanical drug, in 5XFAD and APP/PS1 transgenic mice which underwent daily oral treatment with 30 or 100 mg/kg DA-9803 or vehicle alone. Behavioral testing and longitudinal imaging of amyloid deposits and intracellular calcium in neurons with multiphoton microscopy was performed.

Results

Chronic administration of DA-9803 restored behavioral deficits in 5XFAD mice and reduced amyloid-? levels. DA-9803 also prevented progressive amyloid plaque deposition in APP/PS1 mice. Elevated calcium, detected in a subset of neurons before the treatment, was restored and served as a functional indicator of treatment efficacy in addition to the behavioral readout. In contrast, mice treated with vehicle alone continued to progressively accumulate amyloid plaques and calcium overload.

Conclusions

In summary, treatment with DA-9803 prevented structural and functional outcome measures in mouse models of AD. Thus, DA-9803 shows promise as a novel therapeutic approach for Alzheimer's disease.

SUBMITTER: Pagnier GJ 

PROVIDER: S-EPMC5789736 | biostudies-literature | 2018 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Novel botanical drug DA-9803 prevents deficits in Alzheimer's mouse models.

Pagnier Guillaume J GJ   Kastanenka Ksenia V KV   Sohn Miwon M   Choi Sangzin S   Choi Song-Hyen SH   Soh HyeYeon H   Bacskai Brian J BJ  

Alzheimer's research & therapy 20180129 1


<h4>Background</h4>Alzheimer's disease (AD) is a neurodegenerative disorder characterized by deposition of amyloid plaques and disruption of neural circuitry, leading to cognitive decline. Animal models of AD deposit senile plaques and exhibit structural and functional deficits in neurons and neural networks. An effective treatment would prevent or restore these deficits, including calcium dyshomeostasis observed with in-vivo imaging.<h4>Methods</h4>We examined the effects of DA-9803, a multimod  ...[more]

Similar Datasets

| S-EPMC6908963 | biostudies-literature
| S-EPMC6190663 | biostudies-literature
| S-EPMC5694549 | biostudies-literature
| S-EPMC2726352 | biostudies-literature
| S-EPMC2585842 | biostudies-other
| S-EPMC7425324 | biostudies-literature
| S-EPMC7725456 | biostudies-literature
| S-EPMC9254908 | biostudies-literature
| S-EPMC7154147 | biostudies-literature
2021-07-14 | GSE180001 | GEO